• ONA Therapeutics, Absolute Antibody and RIC partner to create new type of biologic

    Friday December 18th 2020

  • OHMX.bio and Fujirebio Europe receive grant of 720K EURO to incorporate third generation sequencing into clinical in vitro diagnostics platform

    Tuesday December 8th 2020

  • Newton Biocapital I invests in Perseus Proteomics Inc. in Japan to develop therapeutic antibodies for the treatment of blood cancers

    Tuesday December 1st 2020

  • Novalis Biotech announces first closing of its second healthcare fund

    Tuesday November 24th 2020

  • Aphea.Bio secures €14 million Series B financing to further develop its next generation agricultural biologicals

    Friday November 20th 2020

  • AbolerIS Pharma raises €2.5M in seed financing from Turenne Santé/Sham Innovation Santé and Newton Biocapital

    Tuesday November 17th 2020

  • CANNOVEX receives EUR 0.5 million grant for development of nanofibrous films for transmucosal uptake of cannabinoids

    Monday October 19th 2020

  • Sanquin finds investors for plasma-derived medicines manufacturing subsidiaries Plasma Industries and Plasma Products

    Tuesday October 13th 2020

  • Your news here?

  • BISC Global awarded a Eurostars grant for the development of a machine learning based antigen discovery and T-cell epitope prediction software.

    Friday October 9th 2020

  • Complix receives €1.2 million VLAIO grant to develop a novel and differentiated class of anti-Covid-19 Alphabody™ therapeutics

    Wednesday October 7th 2020

  • Biotalys awarded €1.1 million VLAIO research grant

    Thursday October 1st 2020

Strategic Partners